Skip to main content

Virax raises $3m for Pathway takeover

25/03/2014 - 12:10

Bookmark

Save articles for future reference.

Virax Holdings has completed a $3 million equity placement to sophisticated investors to support its acquisition last week of Pathway Oncology.

X

To read our articles you will need to either login or subscribe.